Athanasios Pipilis
Overview
Explore the profile of Athanasios Pipilis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanakakis I, Stafylas P, Tsigkas G, Nikas D, Synetos A, Avramidis D, et al.
Hellenic J Cardiol
. 2022 Mar;
67:1-8.
PMID: 35307346
Objective: Acute myocardial infarction (AMI) is one of the leading causes of death; however, updated data regarding clinical presentation and current management are missing in Greece. This study aimed to...
2.
Kanakakis I, Stafylas P, Avramidis D, Dagre A, Latsios G, Nikas D, et al.
Hellenic J Cardiol
. 2020 Jul;
62(3):244-247.
PMID: 32673758
No abstract available.
3.
Farmakis D, Davlouros P, Giamouzis G, Giannakoulas G, Pipilis A, Tsivgoulis G, et al.
Cardiology
. 2018 Jul;
140(2):126-132.
PMID: 29975925
Direct or new oral anticoagulants (NOACs), including the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, have recently revolutionized the field of antithrombotic therapy...
4.
Makrygiannis S, Rizikou D, Patsourakos N, Lampakis M, Margariti A, Ampartzidou O, et al.
Aust Crit Care
. 2017 Aug;
31(5):274-277.
PMID: 28851605
Background: Data regarding new onset atrial fibrillation (nAF) in general, non-cardiac, intensive care unit (ICU) patients are limited. However, it has been suggested that nAF is associated with worse clinical...
5.
Pipilis A, Makrygiannis S, Anagnostou G, Kaliampakos S, Tsakonas G, Sourlas N, et al.
J Thromb Thrombolysis
. 2017 May;
44(1):9-13.
PMID: 28488236
According to current recommendations, patients on dabigatran should stop the drug 24-96 h before scheduled surgery. This may seem too long for non-elective cases. The aim of our study was...
6.
Sourlas N, Papavasileiou L, Makrygiannis S, Pipilis A
Hellenic J Cardiol
. 2016 Oct;
PMID: 27773613
No abstract available.
7.
Liakou C, Koh J, Tsimpidakis A, Rios K, Paskalis C, Pipilis A, et al.
Case Rep Med
. 2016 Apr;
2016:6723575.
PMID: 27092182
Amyloidosis is the extracellular fibril deposition of a variety of proteins, many of which circulate as plasma ingredients. It is a disease difficult to identify due to its nonspecific symptoms...
8.
Pipilis A, Farmakis D, Kaliambakos S, Goudevenos J, Lekakis J
J Cardiovasc Med (Hagerstown)
. 2016 Jan;
18(7):545-549.
PMID: 26825445
Background: Patients with atrial fibrillation aged 75 years or older have a CHA2DS2VASc score that dictates oral anticoagulants. We recorded physicians' anticoagulation attitudes in elderly patients with atrial fibrillation and...
9.
Pipilis A, Makrygiannis S, Chrisanthopoulou E, Sourlas N, Kaliambakos S, Ntailianas P
Hellenic J Cardiol
. 2014 Nov;
55(6):499-509.
PMID: 25432202
No abstract available.
10.
Pipilis A, Farmakis D, Kaliambakos S, Antoniou A, Goudevenos J, Lekakis J
Int J Cardiol
. 2014 May;
175(3):569-70.
PMID: 24874899
No abstract available.